Picture Berlin Partner Bionnale 2021 Digital Event 650x80px

News > All

Total search results: 8369 | Ordered by Date (descending)
1 2 3 ... 82 83 84  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Alligator Bioscience AB. (4/15/21). "Press Release: Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy". Lund. 2021-04-15
Ori Biotech Ltd.. (4/14/21). "Press Release: ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers". London & Woodcliff Lake, NJ. 2021-04-14
BioVersys AG. (4/14/21). "Press Release: BioVersys Receives €20 Million in EU financing to Support Development of New Antibiotics". 2021-04-14
Evotec SE. (4/13/21). "Press Release: Evotec Launches »beLAB2122«, Translating Academic Innovation from Leading German Life Science Region in Collaboration with Bristol Myers Squibb". Hamburg. 2021-04-13
Quercis Pharma AG. (4/13/21). "Press Release: Quercis Announces Executive Leadership Appointments". Zug. 2021-04-13
Genovis AB. (4/13/21). "Press Release: Genovis and Waters Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization". 2021-04-13
Congenica Ltd.. (4/13/21). "Press Release: Congenica and Camtech Diagnostics Agree Strategic Partnership to Support Genomic Analysis Expansion in Asia". Cambridge & Singapore. 2021-04-13
Repertoire Immune Medicines. (4/13/21). "Press Release: Repertoire Immune Medicines Secures $189M Financing to Advance Pipeline Programs and Discovery Platform Directed at Cellular Immune Targets". Cambridge, MA. 2021-04-13
Kurma Partners. (4/13/21). "Press Release: Jean-François Rivassou Joins Kurma Partners as Partner". Paris. 2021-04-13
Biognosys AG. (4/13/21). "Press Release: Biognosys Announces Strategic Agreement with Siemens Healthineers". 2021-04-13
F2G Ltd.. (4/12/21). "Press Release: Francesco Maria Lavino Appointed Chief Executive Officer of F2G Ltd". Manchester & Vienna. 2021-04-12
Cellbox Solutions GmbH. (4/12/21). "Press Release: Cellbox Solutions Announces New Headquarters". Hamburg. 2021-04-12
CellGenix GmbH. (4/12/21). "Press Release: CellGenix Appoints Daniel Spatz as Vice President Sales, Marketing & Logistics and Member of the Management Team". Freiburg. 2021-04-12
TreeFrog Therapeutics S.A.S.. (4/12/21). "Press Release: World first – TreeFrog Therapeutics Announces the Production of a Single Batch of 15 Billion iPS cells in a 10L Bioreactor with Exponential Amplification of 276-fold per Week". Bordeaux. 2021-04-12
DiaSorin S.p.A.. (4/11/21). "Press Release: DiaSorin to Acquire Luminex Corporation for USD 37.00 per Share or Approximately USD 1.8 Billion". Saluggia. 2021-04-11
Sanofi S.A.. (4/9/21). "Press Release: Sanofi Acquires Tidal Therapeutics, Adding Innovative mRNA-based Research Platform with Applications in Oncology, Immunology, and other Disease Areas". Paris & Cambridge, MA. 2021-04-09
Future Planet Capital Ltd.. (4/8/21). "Press Release: Future Planet Acquires One of the UK’s Oldest VC Firms". 2021-04-08
Hologic, Inc.. (4/8/21). "Press Release: Hologic to Acquire Mobidiag, Innovator in Near-Patient, Acute Care Diagnostic Testing, for Approximately $795 Million". Marlborough, MA. 2021-04-08
Royal Philips. (4/8/21). "Press Release: Philips and Ibex Medical Analytics Team to Accelerate Adoption of AI-powered Digital Pathology". Amsterdam & Tel Aviv. 2021-04-08
Delta 4 GmbH. (4/7/21). "Press Release: Delta 4 Announces Closing of Multi-million Series A Financing Round". Vienna. 2021-04-07
Metagenomi Inc.. (4/7/21). "Press Release: Metagenomi Announces the Addition of Leading Immuno-oncology Clinical Research Experts to Its Scientific Advisory Board". Emeryville, CA. 2021-04-07
Artios Pharma Ltd.. (4/7/21). "Press Release: Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies". Cambridge & New York, NY. 2021-04-07
Metagenomi Inc.. (4/7/21). "Press Release: Metagenomi Extends Series A Financing from RA Capital and Welcomes Andrew Levin to Its Board of Directors". Emeryville, CA. 2021-04-07
Valneva S.E.. (4/6/21). "Press Release: Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001". Saint-Herblain. 2021-04-06
ADC Therapeutics S.A.. (4/6/21). "Press Release: Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer". Boston, MA, Shanghai & Lausanne. 2021-04-06
Congenica Ltd.. (4/6/21). "Press Release: Congenica Appoints Jayesh Pankhania as Chief Financial Officer". Cambridge. 2021-04-06
Oxford Biomedica plc. (5/6/21). "Press Release: Oxford Biomedica Signs a New Three Year Development & Supply Agreement with Boehringer Ingelheim for the Manufacture and Supply of Viral Vectors". Oxford. 2021-04-06
Metrion Biosciences Ltd.. (4/6/21). "Press Release: Metrion Biosciences Closes £2.7m New Equity Financing. Financing Led by Gresham House Ventures". Cambridge. 2021-04-06
Achilles Therapeutics plc. (4/6/21). "Press Release: Achilles Therapeutics Announces Closing of $175.5 Million Initial Public Offering". London. 2021-04-06
Drägerwerk AG & Co. KGaA. (4/1/21). "Press Release: Dräger Acquires Majority Share of Swiss Medical Technology Start-up STIMIT". Lübeck. 2021-04-01
OncoResponse, Inc.. (3/31/21). "Press Release: OncoResponse Raises $40.6 Million Series C Financing". Seattle, WA. 2021-03-31
Knauer Wissenschaftliche Geräte GmbH. (3/31/21). "Press Release: Carsten Losch Joins General Management at Knauer". 2021-03-31
Qlucore AB. (3/31/21). "Press Release: Qlucore Secures SEK 30 Million (USD 3.5m) for International Expansion". 2021-03-31
Rentschler Biopharma SE. (3/31/21). "Press Release: Rentschler Biopharma Appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation". Laupheim & Milford, MA. 2021-03-31
Pyxis Oncology. (3/30/21). "Press Release: Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics". Cambridge, MA. 2021-03-30
Achilles Therapeutics plc. (3/30/21). "Press Release: Achilles Therapeutics Announces Pricing of Initial Public Offering". London. 2021-03-30
Cell-Easy. (3/29/21). "Press Release: Cell-Easy Strengthens Executive Team with Two New Highly Experienced Members". Toulouse. 2021-03-29
Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces Additional Financing Plans". London. 2021-03-26
Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing". London. 2021-03-26
Inbrain Neuroelectronics S.L.. (3/26/21). "Press Release: Inbrain Neuroelectronics Raises Over €14M Series A". Barcelona. 2021-03-26
Olink Holding AB. (3/25/21). "Press Release: Olink Holding AB (publ) Announces Pricing of Initial Public Offering". Uppsala. 2021-03-25
Eliem Therapeutics, Inc.. (3/25/21). "Press Release: Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders". Seattle, WA & Cambrigde. 2021-03-25
Leyden Laboratories B.V.. (3/25/21). "Press Release: Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital". Ams 2021-03-25
Immunai. (3/25/21). "Press Release: Immunai Acquires Dropprint Genomics and Strengthens Leadership Team with Experts in Immunology to Expand Target Discovery Capabilities". New York, NY. 2021-03-25
Immuneering Corporation. (3/25/21). "Press Release: Immuneering Expands Leadership Team with Appointment of Carolina Garcia Rizo, Ph.D., MBA, as Chief Business Officer". Cambridge, MA. 2021-03-25
Merck & Co., Inc.. (3/24/21). "Press Release: Merck Appoints Caroline Litchfield Chief Financial Officer". Kenilworth, NJ. 2021-03-24
Scipher Medicine. (3/24/21). "Press Release: Scipher Medicine Announces $82 Million Financing". Waltham, MA. 2021-03-24
Enterome S.A.. (3/24/21). "Press Release: Enterome Receives FDA IND Clearance for EO2463, an ‘OncoMimic’ based Immunotherapy Targeting Liquid Tumors". 2021-03-24
ProBioGen AG. (3/24/21). "Press Release: ProBioGen Enters into Agreement with Nobelpharma for Manufacturing Process Development of their Vaccine Project". Berlin. 2021-03-24
Leukocare AG. (3/24/21). "Press Release: Leukocare and Formycon Cooperate in the Development of High-quality Biopharmaceuticals". Martinsried. 2021-03-24
Lava Therapeutics B.V.. (3/24/21). "Press Release: Lava Therapeutics Announces Pricing of Initial Public Offering". Utrecht & Philadelphia, PA. 2021-03-24
Arix Bioscience plc. (3/24/21). "Press Release: Strategy Implementation Review". London. 2021-03-24
Numares AG. (3/24/21). "Press Release: Numares Announces FDA 510(k) Submission of Axinon System, a NMR Platform for Metabolomics-based, AI-driven Diagnostics". Boston, MA & Regensburg. 2021-03-24
Evolva S.A.. (3/24/21). "Press Release: Evolva Announces New Chief Financial Officer". Reinach. 2021-03-24
Step Pharma S.A.S.. (3/24/21). "Press Release: Step Pharma Raises EUR35 Million in Series B Financing to Advance First in Class CTPS1 inhibitor into the Clinic in T Cell Malignancies". Archamps. 2021-03-24
Cytosurge AG. (3/24/21). "Press Release: Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks". Zürich. 2021-03-24
Meatable. (3/23/21). "Press Release: Meatable Raises $47 Million Series A to Continue Scaling Trajectory and Expand its Product Portfolio with Beef". 2021-03-23
PhoreMost Ltd.. (3/23/21). "Press Release: PhoreMost Closes £33M ($46M) Series B Financing". Cambridge. 2021-03-23
Dunad Therapeutics. (3/23/21). "Press Release: Dunad Therapeutics Emerges to Develop Next-generation Small Molecule Therapeutics Based on First Tuneable Targeted Protein Degradation Technology". Cambridge. 2021-03-23
Evotec SE. (3/22/21). "Press Release: Evotec and Takeda Enter Strategic RNA Targeting Drug Discovery and Development Alliance". Hamburg. 2021-03-22
Dotmatics Ltd.. (3/22/21). "Press Release: Insightful Science Joins Forces with Dotmatics to Form a Leading Cloud-First Scientific R&D Company". Bishop’s Stortford & San Diego, CA. 2021-03-22
Rentschler Biopharma SE. (3/22/21). "Press Release: Rentschler Biopharma and Leukocare Extend Service Offering with Joint U.S. Site". Geneva & Newton, MA. 2021-03-22
Aber Instruments. (3/22/21). "Press Release: Aber Introduces Futura neotf On-line Single-use Biomass Sensor". Aberystwyth. 2021-03-22
Novartis AG. (3/22/21). "Press Release: Novartis Appoints Karen Hale as Chief Legal Officer". Basel. 2021-03-22
Elicera Therapeutics AB. (3/22/21). "Press Release: Elicera Announces Appointment of ATMP Specialist Karin Hoogendoorn to the Board". Gothenburg. 2021-03-22
Relief Therapeutics Holding AG. (3/22/21). "Press Release: Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine D 2021-03-22
Auro Biosciences, Inc.. (3/22/21). "Press Release: Aura Biosciences Announces Oversubscribed $80 Million Financing". Cambridge, MA. 2021-03-22
Bruker Corporation. (3/18/21). "Press Release: Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics". San José, CA & Boston, MA. 2021-03-18
Indivumed GmbH. (3/18/21). "Press Release: Indivumed Announces Expansion into Drug Development, Formation of Ix Therapeutics. Joint Venture with Xlife Sciences". Hamburg. 2021-03-18
Alligator Bioscience AB. (3/18/21). "Press Release: Alligator Bioscience Appoints Søren Bregenholt as New CEO". Lund. 2021-03-18
Selexis S.A.. (3/18/21). "Press Release: SpyBiotech Licenses Selexis Best-in-Class Cell Line Development Technologies to Advance Human Cytomegalovirus VLP Vaccine Program". Geneva. 2021-03-18
Aktis Oncology. (3/18/21). "Press Release: Aktis Oncology Announces $72m Series A Financing to Advance Breakthrought Radiopharmaceuticals to Treat Solid Tumors". Cambridge, MA. 2021-03-18
Life Sciences Partners (LSP). (3/18/21). "Press Release: LSP Announces Closing of Upsized $120 Million Nasdaq IPO of European Biotech Acquisition Corp (EBAC) Targeting European Biotech". Amsterdam. 2021-03-18
Nordic Nanovector ASA. (3/18/21). "Press Release: Nordic Nanovector Appoints Experienced Pharmaceutical Company Leader Peter L. Braun as Chief Executive Officer". Potsdam & Berlin. 2021-03-18
Scienion AG. (3/18/21). "Press Release: Gilupi and Scienion Announce Collaboration for the Development of Single-Cell CTC Analysis". Potsdam & Berlin. 2021-03-18
Vaccitech Ltd.. (3/17/21). "Press Release: Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results". Oxford. 2021-03-17
Amphista Therapeutics Ltd.. (3/17/21). "Press Release: Amphista Therapeutics Raises $53M in Oversubscribed Series B Round to Advance Next Generation Targeted Protein Degradation Assets". Glasgow. 2021-03-17
Axol Bioscience Ltd.. (3/17/21). "Press Release: Axol Bioscience and Censo Biotechnologies Announce Merger". Cambridge. 2021-03-17
Seekyo S.A.S.. (3/17/21). "Press Release: Seekyo Raises over €650,000 from Business Angels and Bpifrance". Poitiers. 2021-03-17
Advent France Biotechnology S.A.S.. (3/17/21). "Press Release: Advent France Biotechnology Appoints Alejo Chorny, PhD, as Operating Partner and Head of New Spanish Operations". Paris & Barcelona. 2021-03-17
ExeVir Bio B.V.. (3/16/21). "Press Release: ExeVir Announces Close of $50 Million / EUR42 million Series A Financing". Belgium. 2021-03-16
Alchemab Therapeutics Ltd.. (3/16/21). "Press Release: Alchemab and Medicines Discovery Catapult to Develop Landmark Novel Antibody Therapy for Huntington’s disease". London. 2021-03-16
CytoSeek Ltd.. (3/16/21). "Press Release: CytoSeek Raises £3.57M ($5M) to Advance Its Mission to Develop the Next Generation of Cell Therapies for Cancer". Bristol. 2021-03-16
Leica Microsystems AG. (3/16/21). "Press Release: Leica Microsystems Acquires Aivia, a Leading AI-enabled 3D Microscopy, Image Visualization and Analysis Software Solution". Wetzlar. 2021-03-16
Ryvu Therapeutics. (3/16/21). "Press Release: Ryvu Therapeutics Reports Financial Results for 2020". Kraków. 2021-03-16
Inflammatix, Inc.. (3/16/21). "Press Release: Inflammatix Secures $102 Million in Series D Financing Led by D1 Capital Partners to Commercialize Novel Host Response Diagnostics". Burlingame, CA. 2021-03-16
Roche. (3/15/21). "Press Release: Roche Signs Definitive Merger Agreement with GenMark Diagnostics, Inc., to Access Novel Technology to Test for Broad Range of Pathogens with One Patient Sample". Basel. 2021-03-15
Lava Therapeutics B.V.. (3/15/21). "Press Release: Lava Therapeutics B.V. Appoints Edward F. Smith as Chief Financial Officer". Utrecht & Philadelphia, PA. 2021-03-15
Univercells S.A.. (3/15/21). "Press Release: Univercells, Univercells Technologies and Gamma Biosciences Announce Mathias Garny as New CEO of Univercells Technologies". Brussels. 2021-03-15
Antiverse Ltd.. (3/15/21). "Press Release: Antiverse Raises £1.4 Million ($2 Million USD) to Advance Its AI Antibody Drug Discovery Platform". 2021-03-15
Cellink AB. (3/12/21). "Press Release: Cellink AB (publ) Announces the Completion of the Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Overall Amount of SEK 3.0 Billion [NOT FOR US, CA, AU, 2021-03-12
Relief Therapeutics Holding AG. (3/12/21). "Press Release: Relief Announces CHF 10 Million Private Placement". Geneva. 2021-03-12
Monte Rosa Therapeutics. (3/12/21). "Press Release: Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform". Boston, MA. 2021-03-12
InfanDx AG. (3/11/21). "Press Release: Neonatal Diagnostics Company InfanDx Closes Interim Financing Round". Cologne. 2021-03-11
Cellink AB. (3/11/21). "Press Release: Cellink AB Announces an Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Expected Amount of SEK 2.75 Billion [NOT FOR US, CA, et al.]". Gothenburg. 2021-03-11
Touchlight Genetics Ltd.. (3/11/21). "Press Release: Touchlight Raises £42 Million ($58 Million) to Meet Unprecedented Global DNA Demand". Hampton. 2021-03-11
Cellink AB. (3/10/21). "Press Release: Cellink Has Entered into an Agreement to Acquire MatTek, the Global Leader in In-vitro Technology and Alternative Drug Testing Models". 2021-03-10
Enterome S.A.. (3/10/21). "Press Release: Enterome Strengthens Its Leadership Team with the Appointment of Anne Dagallier as Chief Business Officer". 2021-03-10
AgomAb Therapeutics N.V.. (3/10/21). "Press Release: AgomAb Therapeutics Raises $74 Million Series B to Advance Regenerative Pathway Modulators". Ghent. 2021-03-10
BellaSeno GmbH. (3/10/21). "Press Release: BellaSeno and Fraunhofer Institute for Production Technology IPT Receive EUR 1.4 Million BMBF Grant". Leipzig & Aachen. 2021-03-10
1 2 3 ... 82 83 84  next pagenext page


Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top